Triple Hair
Triple Hair
  • Publications
  • Contact
  • FR
  • Company
  • Science
  • Investors
  • Clinical trials
  • Products
    • PRESCRIPTION l Therapy-7
    • DRUG-FREE l Therapy-16
    • Hair Loss Rx Consult
    • RIZN
    • Plenty Natural
  • Company
  • Science
  • Investors
  • Clinical trials

Satish Asotra, Ph.D., MBA

Posted on June 7, 2020 (July 27, 2026) by Jean-Philippe Gravel

Post navigation

 Jean Lachapelle, M. Sc.Chanèle Dumontier, CPA 

Search

Recent Posts

  • Triple Hair Expands Global Phase III Program for TH07 with Launch of 500-Patient Trial in India
  • Triple Hair Doses First Patient in Phase III Clinical Trial in Canada for Male Androgenic Alopecia
  • Triple Hair’s Feature in the NY Post
  • Triple Hair Group Signs Licensing Agreement for the Brazilian Market with Aché
  • Triple Hair Group Strengthens Leadership Team with Appointment of Paul Sowyrda to its Board of Directors

Recent Comments

    Triple Hair is a clinical-stage Canadian
    biotechnology company specialized in the
    development of innovative treatments for alopecia.

    Revolutionary
    hair growth
    therapies

    • Company
    • Products
    • TH07
    • Science
    • Contact
    • TH16
    • Investors
    • Terms and Conditions
    • Privacy Policy

    Copyright © 2020 | Triple Hair

    Clinical Trials
    Looking to invest?